Latest DEF 14A proxy statements
NYSE
Virtus Investment Partners announces its 2026 Annual Meeting of Shareholders, detailing director elections, auditor ratification, and executive compensation.
NYSE
USANA Health Sciences announces its 2026 Annual Meeting of Shareholders, to be held virtually on May 20, 2026, with key proposals including director elections and executive compensation.
NASDAQ
Xcel Energy Inc. has announced its 2026 Annual Meeting of Shareholders, set for May 20, 2026, to vote on director nominees, executive compensation, and auditor ratification.
NYSE
SmartFinancial, Inc. has announced its 2026 Annual Meeting of Shareholders, scheduled for May 21, 2026, to elect directors, ratify auditors, and vote on executive compensation.
NYSE
Finance of America Companies Inc. has issued its proxy statement for the Annual Meeting of Stockholders scheduled for May 15, 2026, detailing proposals for director elections, executive compensation, and auditor ratification.
NASDAQ
Lake Shore Bancorp, Inc. has issued its proxy statement for the upcoming Annual Meeting of Shareholders on May 20, 2026, detailing director elections, executive compensation votes, and auditor ratification.
NYSE
LAZ
Lazard, INCLazard's 2026 Proxy Statement details upcoming shareholder votes on director elections, executive compensation, board declassification, and incentive plan amendments, alongside a review of 2025 performance.
NYSE
XPO
Xpo, INCXPO, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on May 19, 2026, with key proposals including director elections and executive compensation.
NYSE
CVX
Chevron CORPChevron Corporation has announced its 2026 Annual Meeting of Stockholders, scheduled for May 27, 2026, and provided details on director nominees, board committee compositions, and executive compensation.
NASDAQ
GERN
Geron CORPGeron Corporation has announced its 2026 Annual Meeting of Stockholders, scheduled for May 20, 2026, to elect directors, approve equity plan amendments, and ratify auditor selection.
NASDAQ
MNKD
Mannkind CORPMannKind Corporation has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, executive compensation, and auditor ratification.
NASDAQ
Rush Enterprises announces its 2026 Annual Meeting of Shareholders, set for May 19, 2026, to elect directors, approve executive compensation, and ratify auditor appointment.
NASDAQ
Alkami Technology, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, auditor ratification, and executive compensation.
NASDAQ
Tandem Diabetes Care, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for May 20, 2026, detailing proposals for director elections, executive compensation, and plan amendments.
AMEX
abrdn Emerging Markets ex-China Fund announces its annual stockholder meeting on May 27, 2026, to elect one Class III Director.
NASDAQ
AMGN
Amgen INCAmgen Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on May 19, 2026, detailing strong 2025 performance in drug development, sales growth, and manufacturing investments.
NYSE
abrdn Income Credit Strategies Fund announces its annual shareholder meeting on May 27, 2026, to elect trustees and address other business.
NYSE
Meritage Homes Corporation is holding its 2026 Annual Meeting of Stockholders virtually on May 21, 2026, to elect directors, ratify auditors, and vote on executive compensation and shareholder proposals.
NYSE
Aberdeen India Fund, Inc. announces its Annual Meeting of Stockholders to be held on May 27, 2026, with key proposals including the election of directors and consideration of director term continuation.
NYSE
Aberdeen Global Dynamic Dividend Fund, abrdn Total Dynamic Dividend Fund, and abrdn Global Premier Properties Fund have announced their annual shareholder meetings scheduled for May 27, 2026, with the primary agenda item being the election of two Class III Trustees for each fund.
NYSE
Aberdeen Global Dynamic Dividend Fund, abrdn Total Dynamic Dividend Fund, and abrdn Global Premier Properties Fund have announced their annual shareholder meetings scheduled for May 27, 2026, with the primary agenda item being the election of two Class III Trustees for each fund.
NYSE
Aberdeen Global Dynamic Dividend Fund, abrdn Total Dynamic Dividend Fund, and abrdn Global Premier Properties Fund have announced their annual shareholder meetings scheduled for May 27, 2026, with the primary agenda item being the election of two Class III Trustees for each fund.
AMEX
Abrdn Asia-Pacific Income Fund and Abrdn Australia Equity Fund have announced their annual stockholder meetings scheduled for May 27, 2026, to elect directors and consider governance matters.
AMEX
Abrdn Asia-Pacific Income Fund and Abrdn Australia Equity Fund have announced their annual stockholder meetings scheduled for May 27, 2026, to elect directors and consider governance matters.
NYSE
Dollar General Corporation has announced its 2026 Annual Meeting of Shareholders will be held virtually on May 28, 2026, and has proposed a slate of directors, including a new nominee, Gregory H. Hicks.
NYSE
Envista Holdings Corporation announced its 2026 Annual Meeting of Stockholders, scheduled for May 19, 2026, to elect directors, ratify auditors, and vote on executive compensation.
NYSE
Abrdn Healthcare Investors, Abrdn Life Sciences Investors, Abrdn Healthcare Opportunities Fund, and Abrdn World Healthcare Fund have issued a joint proxy statement detailing their upcoming annual shareholder meetings on May 27, 2026, primarily for the election of Trustees.
NYSE
Abrdn Healthcare Investors, Abrdn Life Sciences Investors, Abrdn Healthcare Opportunities Fund, and Abrdn World Healthcare Fund have issued a joint proxy statement detailing their upcoming annual shareholder meetings on May 27, 2026, primarily for the election of Trustees.
NYSE
Abrdn Healthcare Investors, Abrdn Life Sciences Investors, Abrdn Healthcare Opportunities Fund, and Abrdn World Healthcare Fund have issued a joint proxy statement detailing their upcoming annual shareholder meetings on May 27, 2026, primarily for the election of Trustees.
NYSE
Abrdn Healthcare Investors, Abrdn Life Sciences Investors, Abrdn Healthcare Opportunities Fund, and Abrdn World Healthcare Fund have issued a joint proxy statement detailing their upcoming annual shareholder meetings on May 27, 2026, primarily for the election of Trustees.